Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.3150
-0.0094 (-2.90%)
At close: Aug 26, 2025

Viva Biotech Holdings Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
1,8371,9872,1562,3802,104696.96
Upgrade
Revenue Growth (YoY)
-7.95%-7.84%-9.41%13.10%201.89%115.74%
Upgrade
Cost of Revenue
1,1491,2991,4171,5641,453392.09
Upgrade
Gross Profit
687.68687.4738.43815.68650.98304.87
Upgrade
Selling, General & Admin
373.07364.12409.66404.45320.29123.26
Upgrade
Research & Development
85.4987.99127.97135.8492.3866.04
Upgrade
Other Operating Expenses
---3.37-3.03
Upgrade
Operating Expenses
459.07457.73545.75549.7414.08192.33
Upgrade
Operating Income
228.61229.67192.68265.98236.9112.54
Upgrade
Interest Expense
-41.06-53.89-176.58-184.67-183.11-62.13
Upgrade
Interest & Investment Income
20.9220.527.3821.6126.5816.71
Upgrade
Earnings From Equity Investments
-0.51-0.1----0.49
Upgrade
Currency Exchange Gain (Loss)
12.2916.18-51.01-146.3931.41-
Upgrade
Other Non Operating Income (Expenses)
22.8932.74210.93-4.33188.05-542.14
Upgrade
EBT Excluding Unusual Items
243.13245.1203.39-47.81299.83-475.51
Upgrade
Gain (Loss) on Sale of Investments
79.2691.12-11.68-364.1855.16113.24
Upgrade
Gain (Loss) on Sale of Assets
-1.91-1.910.28-1.9-5.21.61
Upgrade
Asset Writedown
-38.61-38.61-25.19-6.57-2.1-
Upgrade
Other Unusual Items
---222.76-38.7-4.45
Upgrade
Pretax Income
281.88295.71-55.95-459.17347.7-356.21
Upgrade
Income Tax Expense
55.573.7243.8445.0647.1422.66
Upgrade
Earnings From Continuing Operations
226.39221.99-99.79-504.22300.56-378.87
Upgrade
Minority Interest in Earnings
-54.1-54.69-16.32-24.26-13.01-8.01
Upgrade
Net Income
172.29167.29-116.11-528.48287.55-386.88
Upgrade
Net Income to Common
172.29167.29-116.11-528.48287.55-386.88
Upgrade
Shares Outstanding (Basic)
2,1212,1371,9401,9151,9121,572
Upgrade
Shares Outstanding (Diluted)
3,0522,8682,0291,9151,9711,572
Upgrade
Shares Change (YoY)
48.61%41.39%5.91%-2.81%25.41%5.83%
Upgrade
EPS (Basic)
0.080.08-0.06-0.280.15-0.25
Upgrade
EPS (Diluted)
0.060.06-0.14-0.280.08-0.25
Upgrade
Free Cash Flow
214.34183.32195.73136.72-487.35-549.44
Upgrade
Free Cash Flow Per Share
0.070.060.100.07-0.25-0.35
Upgrade
Dividend Per Share
-----0.023
Upgrade
Dividend Growth
-----29.28%
Upgrade
Gross Margin
37.44%34.60%34.26%34.28%30.94%43.74%
Upgrade
Operating Margin
12.45%11.56%8.94%11.18%11.26%16.15%
Upgrade
Profit Margin
9.38%8.42%-5.39%-22.21%13.67%-55.51%
Upgrade
Free Cash Flow Margin
11.67%9.23%9.08%5.75%-23.16%-78.83%
Upgrade
EBITDA
431.96432.78391.01436.35369.94164.35
Upgrade
EBITDA Margin
23.52%21.78%18.14%18.34%17.58%23.58%
Upgrade
D&A For EBITDA
203.35203.11198.33170.37133.0451.81
Upgrade
EBIT
228.61229.67192.68265.98236.9112.54
Upgrade
EBIT Margin
12.45%11.56%8.94%11.18%11.26%16.15%
Upgrade
Effective Tax Rate
19.69%24.93%--13.56%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.